Rocket Lab (RKLB)

Space Systems drove the latest fiscal quarter’s revenue growth. Launch Services revenue declined from the comparable fiscal quarter, so the improvement should not be mistaken for broad strength across the business.

The operating margin improved, meaning the operating loss absorbed a smaller share of revenue. That is useful progress, but quarterly operating cash use worsened rather than following the margin improvement.

Rocket Lab sells access to orbit and the hardware needed to operate there. Launch Services serves customers through rocket missions, while Space Systems supplies spacecraft, components, design and manufacturing services, and on-orbit solutions.

Electron gives Rocket Lab an established launch business. Its private launch range in Mahia offers operational control, but reliable rockets and access to launch pads remain essential. Neutron is a development effort, not an established profitable operation.

The strongest growth evidence is reported Space Systems revenue, not a launch schedule or a development announcement. The primary filing shows revenue recognized both at delivery and over the course of work, with over-time recognition particularly important to Space Systems.

Revenue recognition does not mean the same thing as collecting cash. Rocket Lab also allows certain commercial launch customers to finance milestone payments through subordinated loans. That can support customer commitments, but it leaves Rocket Lab exposed to delayed collections and customer credit risk.

The proposed Iridium acquisition could connect Rocket Lab’s launch and satellite manufacturing capabilities with a communications network. It remains subject to closing conditions and should not be treated as completed expansion or reported revenue.

Rocket Lab’s operating margin is moving in the right direction. The business is generating more revenue relative to its operating loss, which makes the development case more credible.

That does not establish which activity earns attractive margins. The consolidated results do not support assigning profitability to Electron, Neutron or Space Systems separately. What must work next is continued delivery growth without operating costs and development demands swallowing the benefit.

Reported GAAP earnings remain negative. GAAP earnings include non-operating items, so changes in diluted earnings per share are not a clean measure of progress in the underlying business.

The latest quarter’s other non-operating income was negative, not an earnings boost. I would judge progress through operating results and cash use rather than read a changing per-share loss as proof of durable profitability.

Cash is the main weakness in this case. Operations consumed cash in the latest quarter and across the trailing fiscal period. Cash purchases of property, plant and equipment added to that outflow.

Here, cash flow after capital purchases means operating cash flow less the issuer’s reported cash purchases of productive assets. It remained negative, and the latest quarter deteriorated from the preceding fiscal quarter. Improving operating margins have not yet translated into less cash leaving the business.

Rocket Lab needs to fund ongoing operations and productive assets while advancing its development plans. The reported cash flows do not isolate Neutron’s cash cost, so the entire cash deficit should not be attributed to that program.

Cash and equivalents provide a substantial financial cushion, with short-term investments reported separately. Current borrowings were absent, while noncurrent debt and capital lease obligations were modest relative to cash. Immediate borrowing pressure is not the central concern.

That cushion does not make expansion free. Continued cash consumption and the proposed Iridium transaction could alter funding needs. The available transaction context does not establish the financing mix; borrowing could add obligations, while new shares could reduce existing shareholders’ ownership.

This is a milestone-and-funding case, not a positive-earnings valuation exercise. I would not turn current losses into an invented earnings multiple or treat a lower share price as evidence of value.

The evidence needed for a buy is concrete: sustained Space Systems deliveries, reliable Electron operations, credible Neutron progress and improving cash use. Technical milestones matter, but they do not become revenue or profit merely because they are achieved.

Clarity on the proposed Iridium transaction also matters. Completion, funding and integration must strengthen the business without placing an excessive burden on existing shareholders. Until those questions become clearer, waiting is more persuasive than buying.

Rocket Lab has earned an investable rating because its growth comes from an operating business, not just a promise to build rockets. It has not yet earned my buy decision because cash use is worsening while important development and acquisition risks remain unresolved.

I would become more constructive if delivery growth comes with better operating cash flow and disciplined expansion funding. Persistent cash deterioration, customer collection problems or costly development delays would weaken the business case.

• Monitor Space Systems deliveries alongside operating cash flow, not revenue alone.
• Watch Electron reliability, launch-pad access and Neutron development progress.
• Review Iridium closing conditions, financing and any effect on existing shareholders’ ownership.